Biotech

All Articles

Biogen cans SAGE-324 partnership after essential trembling stop working

.Biogen has actually carried out the final rites to its own cooperation along with Sage Rehabs on SA...

AbbVie Parkinson's medicine coming from $8.7 B Cerevel acquistion credit ratings

.On the very same day that some Parkinson's ailment medicines are being actually brought into questi...

Arch closes $3B-plus fund to foster biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Funding Life Sciences, Arc Endeavor Partners is ...

Orion to use Aitia's 'digital doubles' to discover brand new cancer medicines

.Finnish biotech Orion has snooped potential in Aitia's "digital identical twin" tech to establish n...

Windtree's surprise med increases high blood pressure in most current stage 2 win

.While Windtree Therapies has actually battled to expand the financial roots needed to make it throu...

2 cancer cells biotechs merge, producing global impact

.OncoC4 is taking AcroImmune-- and its own in-house scientific production capabilities-- under its o...

Amgen files 1st period 3 win for $400M dermatitis medicine

.Amgen has actually shared (PDF) the 1st stage 3 data on its $400 million dermatitis medication, lin...

Biogen, UCB record phase 3 lupus gain after falling short earlier trial

.Biogen as well as UCB's depend improving right into phase 3 astride a failed research study tries t...

Aptadir wishes brand-new RNA inhibitors may turn around tricky cancers

.Italian biotech Aptadir Rehabs has launched with the guarantee that its pipeline of preclinical RNA...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stockpile

.Wave Life Sciences has satisfied its target in a Duchenne muscular dystrophy (DMD) research, placin...